Dr. Valentin Piëch joined BioMed in 2015 with a background in venture capital, science, and technology. Dr. Piëch founded impact2partners AG, a private venture capital firm with a focus on companies developing treatments and diagnostics for rare diseases. Prior to impact2partners, he was Investment Analyst and then Principal at Nextech Invest, a venture capital firm focusing on oncology. In addition, he is a private investor in a number of startup and growth companies.